Watson Recalls Loxapine Capsules Due to Outdated Patient Outsert
Watson Laboratories is recalling 18,902 bottles of Loxapine 50mg capsules because an outdated patient outsert was used during packaging.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The issue is a documentation/packaging error involving an outdated outsert.
Plain-English summary
Watson Laboratories Inc. is recalling 18,902 bottles of Loxapine Capsules USP, 50mg, 100 count. The recall is due to the use of an outdated version of a patient outsert during the packaging process. The affected product is a prescription-only medication manufactured in Corona, California.
The recall covers nationwide distribution. The specific lot numbers involved are 104432A, 104433A, 121344A, 127024A, and 144290A. The product is identified by NDC # 0591-0372-01.
Consumers and healthcare providers should check their inventory for the listed lot numbers. If the product is found, it should be returned to the pharmacy or distributor for replacement or refund. No specific instructions for immediate disposal are provided in the source text.
The recalled product
- Product
- LOXAPINE (LOXAPINE)
- Brand
- LOXAPINE
- Manufacturer
- Watson Laboratories Inc
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 18,902
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #s: 104432A
- 104433A
- 121344A
- 127024A
- 144290A
UPCs (3)
- 0305910369019
- 0305910370015
- 0305910372019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Watson Laboratories Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same brand · LOXAPINE
- LowWatson Recalls Loxapine Capsules Due to Outdated Patient Outsert Labeling
FDA (Drugs) · 2012-07-11
- LowWatson Loxapine Capsules Recalled for Outdated Patient Outsert Labeling
FDA (Drugs) · 2012-07-11
Same manufacturer · Watson Laboratories Inc
See all →- ModerateWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-05
- SevereWatson Recalls Carisoprodol Tablets Due to Metal Particulates
FDA (Drugs) · 2014-01-15
- ModerateWatson Recalls Next Choice Emergency Contraceptive Tablets Due to Breakage
FDA (Drugs) · 2013-10-16
- SevereWatson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination
FDA (Drugs) · 2013-10-09
- LowWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Defective Seals
FDA (Drugs) · 2013-09-25
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- LowWatson Recalls Oxycodone and Acetaminophen Capsules Due to Low Potency
FDA (Drugs) · 2013-07-31
- ModerateLupin Recalls Lovastatin Tablets Due to CGMP Deviations
FDA (Drugs) · 2019-02-27
- SevereWatson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination
FDA (Drugs) · 2013-10-09
- HighMylan Recalls Loxapine Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2018-05-30
- ModerateAmerican Health Packaging Recalls Lovastatin Tablets Due to CGMP Deviations
FDA (Drugs) · 2019-08-14
- LowLupin Recalls Lisinopril Tablets Due to CGMP Deviations
FDA (Drugs) · 2016-09-28